Xilio Therapeutics To Present Initial Phase 1C Dose Escalation Data For XTX101 In Combination With Atezolizumab In Late-Breaker Poster At SITC 39th Annual Meeting
Xilio Therapeutics To Present Initial Phase 1C Dose Escalation Data For XTX101 In Combination With Atezolizumab In Late-Breaker Poster At SITC 39th Annual Meeting
Xilio Therapeutics将在第39届海丰国际年会上的特别报告海报中展示XTX101联合Atezolizumab的初期1C剂量递增数据
Xilio Therapeutics To Present Initial Phase 1C Dose Escalation Data For XTX101 In Combination With Atezolizumab In Late-Breaker Poster At SITC 39th Annual Meeting
Xilio Therapeutics将在第39届海丰国际年会上的特别报告海报中展示XTX101联合Atezolizumab的初期1C剂量递增数据